Merus N.V. Common Shares
Symbol: MRUS (NASDAQ)
67.15
▼ (-2.04%) -1.400
Company Description:
Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing full-length human multispecific antibody therapeutics, referred to as Biclonics. Merus has only one reportable segment comprising the discovery and development of bispecific therapeutics. Some of its products in the pipeline include MCLA-128; MCLA-117; MCLA-158 and others.
Key Stats
- Today's Open: $68.94
- Today's High: $69.702
- Today's Low: $64.306
- Today's Volume: 391.83K
- Yesterday Close: $68.55
- Yesterday High: $68.7
- Yesterday Low: $65.7442
- Yesterday Volume: 519.29K
- Last Min Volume: 100
- Last Min High: $67.15
- Last Min Low: $67.15
- Last Min VWAP: $67.15
Company Profile
- Name: Merus N.V. Common Shares
- Website: https://www.merus.nl
- Listed Date: 2016-05-19
- Location: 3584 CM UTRECHT, DE
- Market Status: Active
- CIK Number: 0001651311
- SIC Code: 2834
- SIC description: PHARMACEUTICAL PREPARATIONS
- Market Cap: $5.08B
- Round Lot: 100
- Outstanding Shares: 75.63M
- Asset Type: CS
RECENT FILINGS FOR MRUS
| Filing Date | Filing Type | Format |
|---|---|---|
| 2025-08-14 | SCHEDULE 13G/A | View |
| 2025-08-12 | SCHEDULE 13G/A | View |
| 2025-08-05 | 10-Q | View |
| 2025-07-18 | 4 | View |
| 2025-07-17 | 144 | View |
| 2025-07-11 | 4 | View |
| 2025-07-10 | 144 | View |
| 2025-07-09 | 144 | View |
| 2025-06-24 | 4 | View |
| 2025-06-20 | 144 | View |
| 2025-06-05 | 424B5 | View |
| 2025-06-05 | 8-K | View |
| 2025-06-03 | 424B5 | View |
| 2025-05-29 | 8-K | View |
| 2025-05-27 | 4 | View |
| 2025-05-27 | 4 | View |
| 2025-05-27 | 4 | View |
| 2025-05-27 | 4 | View |
| 2025-05-27 | 4 | View |
| 2025-05-27 | 4 | View |